Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02256566 · ClinicalTrials.gov registry record · NA
Cognitive Training for Mood and Anxiety Disorders
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT02256566: Completed NA study, sponsored by Icahn School of Medicine at Mount Sinai.
NCT02256566 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 28 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02256566, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the effects of a computerized cognitive training program (an attention and memory exercise performed on a computer) on thinking and memory in individuals with mood and anxiety disorders, and to begin to test whether this training affects symptoms of depression or anxiety.
Primary Outcome
comparing the proportion of completers (15-18 sessions) between the in-person participants and the participants completing the exercise on their own computers
Interventions
- BEHAVIORAL emotional memory training exercise
- BEHAVIORAL memory training exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2014-09 |
| Est. Completion | 2016-04-20 |
| Phase | NA |
What the finished NCT02256566 record still lists
NCT02256566 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which emotional memory training exercise is the first listed.
NCT02256566 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02256566 about?
NCT02256566 is a clinical study titled "Cognitive Training for Mood and Anxiety Disorders". The purpose of this study is to investigate the effects of a computerized cognitive training program (an attention and memory exercise performed on a computer) on thinking and memory in individuals with mood and anxiety disorders, and to begin to test whether this training affects symptoms of depres...
What is the current status of trial NCT02256566?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2014-09. Estimated completion is 2016-04-20.
What interventions are being tested in trial NCT02256566?
The interventions under investigation include: emotional memory training exercise (BEHAVIORAL), memory training exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT02256566?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02256566's enrollment target sits among peer trials
28 1704th of 2000 higher than 293 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia